Heinrich, Morfit named to AMO board of directors
SANTA ANA, Calif. Advanced Medical Optics on Wednesday announced the election of Daniel Heinrich and Mason Morfit to its board of directors, increasing the company’s board to 10 members.
Since 2003, Heinrich, 51, has been senior vice president and chief financial officer of The Clorox Company. Morfit, 32, is a partner at San Francisco-based ValueAct Capital Partners, a private investment partnership with more than $6 billion in assets.
ValueAct Capital is AMO’s largest stockholder.
“Dan and Mason each bring distinct experiences that will broaden and enrich our board,” stated Jim Mazzo, AMO chairman and chief executive officer. “Dan’s extensive financial expertise and understanding of the global consumer market will be immensely valuable as we execute our complete refractive solution strategy. Mason brings the perspective of a major stockholder with demonstrated governance and capital markets expertise. We are pleased to welcome both gentlemen as new directors and look forward to their contributions.”